Optos plc presents the new P200MA retinal imaging device. Thecompany received FDA clearance in March to market the medicaldevice in the United States.
Optos plc presents the new P200MA retinal imaging device. The company received FDA clearance in March to market the medical device in the United States.
"Aimed at the secondary- as opposed to the primary-care market, we have designed the P200MA to produce an angiographic retinal image product called optomap fa, which we believe will offer eye-care practitioners advanced diagnostic, monitoring, and treatment capabilities for particular eye disorders, including diabetic retinopathy and age-related macular degeneration," said Alastair Atkinson, global product director, Optos plc, in a prepared statement.